✦ LIBER ✦

Identification of a cold-regulated RNA-binding protein from the marine cyanobacteriumSynechococcussp. PCC7002

✍ Scribed by Naoki Sato; Kyonoshin Maruyama; Yoshitaka Nishiyama; Norio Murata

Publisher: Springer
Year: 1997
Tongue: English
Weight: 921 KB
Volume: 110
Category: Article
ISSN: 0918-9440
DOI: 10.1007/bf02506799

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification and expression analysis o

Identification and expression analysis of cold-regulated genes from the cold-hardyCitrusrelativePoncirus trifoliata(L.) Raf.

✍ Mehtap Ṣahin-Çevik; Gloria A. Moore 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 459 KB

Identification of PSF, the polypyrimidin

Identification of PSF, the polypyrimidine tract-binding protein–associated splicing factor, as a developmentally regulated neuronal protein

✍ Grazyna Chanas-Sacré; Cécile Mazy-Servais; Ruddy Wattiez; Sandrine Pirard; Berna 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 941 KB

Determination of the structure of the RN

Determination of the structure of the RNA complex of a double-stranded RNA-binding domain from Drosophila Staufen protein

✍ Andres Ramos; Peter Bayer; Gabriele Varani 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 348 KB

Isolation from cotton shoots of an auxin

Isolation from cotton shoots of an auxin-binding protein regulating the synthesis of RNA

✍ I. A. Arzanova; A. K. Tonlaikh; Sh. I. Salikhov 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 398 KB

Identification of a heparin binding pept

Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein

✍ Heng-Li Chen; Shi-Yi Her; Kuo-Chun Huang; Hsi-Tsung Cheng; Chi-Wei Wu; Suh-Chin 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 374 KB

Rapid Identification of a Protein Bindin

Rapid Identification of a Protein Binding Partner for the Marine Natural Product Kahalalide F by Using Reverse Chemical Proteomics

✍ Andrew M. Piggott; Peter Karuso 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Dedicated to the memory of Professor Paul J. Scheuer Kahalalide F (KF) is in phase II clinical trials as an anticancer drug against a range of difficult to treat solid tumors including prostate, breast and colon carcinomas, neuroblastomas, chondrosarcomas, and osteosarcomas and has relatively low to